XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

+0.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LarryS who wrote (7261)	9/21/1998 9:47:00 PM
From: aknahow	Read Replies (1) of 17367

From the point of view of anyone not expecting a recommendation for an early halt this announcement contains what seems to be good news. Another review shortly before the end of the trial could mean going to the FDA with the data analyzed by the DSMB which will include those patients for which the 90 day follow up information is available. This would perhaps save about 3 months. The above is true only if a halt for positive reasons occurs. Realize some wanted an early halt now but we were all told by XOMA that the expected outcome would be to continue the trial. Understand that as of today the accrual has reached 261. I must admit I do not know what kind of recommendation could be made just before the end of the trial that would have a serious negative impact. I hope not to find out. Adding more subjects would in my opinion be negative because it would seem to imply no early halt and a loss of the potential time savings of not having to review the follow up information. Congratulations to slgonzalez. What happened RobertK, she beat you to it!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next